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Meyer et al. [(1986) FEBS Lett 204,61-66] have shown that phosphoserine can be converted to S-ethylcyste- 
ine by p-elimination and addition of ethanethiol. I have utilised this modification to develop a rapid method 
for the selective purification of phosphoserine-containing peptides from complex mixtures. Changing phos- 
phoserine to Sethylcysteine increases the hydrophobicity of a peptide, altering its mobility during reverse- 
phase chromatography. The number of S-ethylcysteine residues in a peptide can be quantified at the pico- 
molar level, following acid hydrolysis and conversion to the phenylthiocarbamyl derivative. The procedure 
may be particularly powerful for the analysis of peptides that are phosphorylated at multiple sites in vivo. 
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1. INTRODUCTION 
Reversible phosphorylation is a principal 
mechanism for regulating the function of proteins 
in response to extracellular signals, and almost all 
cellular processes in eukaryotes are controlled by 
this post-translational modification [1,2]. It is 
therefore important that rapid and sensitive 
methods are available for identifying and purifying 
phosphopeptides, in particular those containing 
phosphoserine, the most common phosphoamino 
acid present in proteins. 
Recently, Meyer et al. [3] showed that the 
phosphoseryl derivative of the peptide LRRASLG 
could be converted to its S-ethylcysteinyl derivative 
by @elimination of the phosphoseryl residue in 
NaOH and addition of ethanethiol. The phenylthi- 
ohydantoin (Pth) derivative of S-ethylcysteine was 
identified in picomolar amounts during gas-phase 
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sequence analysis of the modified peptide [3]. The 
procedure was not applicable to phosphothreonine 
and phosphotyrosine-containing peptides. 
Here, the conversion of phosphoserine to S- 
ethylcysteine has been exploited to develop a sim- 
ple procedure for the selective isolation of 
phosphoserine-containing peptides. 
2. MATERIALS AND METHODS 
2.1. Preparation of phosphopeptides 
The peptide SPQPSRRGSESSEE, correspond- 
ing to the phosphorylation site on the glycogen- 
binding subunit of protein phosphatase-1 [4], was 
synthesized by Dr Bruce Kemp, Repatriation 
General Hospital, Heidelberg, Victoria, Australia. 
The peptide was phosphorylated by incubation 
with the catalytic subunit of cyclic AMP- 
dependent protein kinase [5] and MgATP, and 
separated from any residual dephosphopeptide by 
reverse-phase liquid chromatography on a Vydac 
Cis column (Separations Group, Hesperia, CA) as 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation f European Biochemical Societies 21 
Volume 215, number 1 FEBS LETTERS May 1987 
described in fig.1. The phosphopeptide eluted 
2 min earlier than the dephosphopeptide. 
Protein phosphatase inhibitor-2 was purified 
from rabbit skeletal muscle in the presence of NaF 
to prevent dephosphorylation, digested with tryp- 
sin and chromatographed on a Vydac Cis column 
[6]. The partially purified peptide EQESSGEEDS- 
DLSPEER, containing two phosphoserine residues 
as judged by fast atom bombardment mass spec- 
trometry (FABMS) [6], was collected and dried on 
a vacuum concentrator. 
2.2. Conversion of phosphoserine to 
S-ethylcysteine 
Phosphoseryl peptides (0.2-2 nmol) were 
dissolved in 50,ul of a reaction mixture consisting 
of ethanethiol (60~1), water (200 pl), dimethyl 
sulphoxide (200,& ethanol (100,~l) and 5 N 
NaOH (65 PI), and incubated for 1 h at 50°C 
under nitrogen. These conditions are identical to 
those described by Meyer et al. [3], except that the 
volume of ethanol was increased by 20 ~1. This m- 
proved the recovery of intact S-ethylcysteinyl pep- 
tides to at least 70%. Incubations were terminated 
I Ro-PTIm ( 
TIME IMINUTES 
o R-ELIMINATION 
lo + ETHANETHIOL 
20 10 ‘0 10 
TIMEIMINUTESI 
Fig. 1. Fractionation of the phosphorylated and dephos- 
phorylated forms of the peptide SPQPSRRGSESSEE on 
a Vydac Cl8 column, before and after modification with 
ethanethiol in NaOH. Reverse-phase liquid 
chromatography was carried out using a Gilson HPLC 
system equipped with a variable-wavelength UV 
detector. The column was developed with a linear 
water-acetonitrile gradient at a flow rate of 1 ml/min. 
(-) Absorbance at 206 nm; (- - -) acetonitrile 
gradient. Gr and Gz (C) represent he two major forms 
of the S-ethylcysteinyl derivative, discussed in the text. 
Table 1 
Amino acid compositions of the peptides SPQPSRRGS- 
ESSEE (G) and EQESSGEEDSDLSPEER (I) after in- 
cubation of phosphorylated and dephosphorylated 
forms with ethanethiol in NaOH 
Amino acid Peptide 
GI ‘32 GD 12 
Asx 2.0 (2) 
Glx 4.0 (4) 3.8 (4) 4.0 (4) 6.8 (7) 
Ser 4.3 (4) 4.1 (4) 5.2 (5) 2.4 (2) 
Gly 1.1 (1) 1.3 (1) 1.3 (1) 2.0 (1) 
Arg 2.1 (2) 1.9 (2) 2.1 (2) 1.0 (1) 
Pro 2.2 (2) 2.1 (2) 2.1 (2) 1.2 (1) 
S-EtCys 0.8 (1) 0.8 (1) 0 1.5 (2) 
Leu 1.0 (1) 
Peptides Gr and G2 denote the two major forms of the 
S-ethylcysteinyl derivative of peptide G (fig. 1C). Peptide 
Gn is the dephosphopeptide doublet (fig.lD). 12 
represents the derivative of peptide I with two S- 
ethylcysteine residues (fig.3). Serine was corrected for 
10% destruction during acid hydrolysis. In quantifying 
S-ethylcysteine, the extinction coefficient of its Ptc 
derivative was assumed to be 96% of the value for Ptc- 
methionine [7] 
by cooling and adding 10 ~1 acetic acid. After dilu- 
tion to 1 ml with water, the reactions were dried, 
dissolved in 0.1% (v/v) trifluoroacetic acid and 
refractionated on the Vydac column as described 
below. 
3. RESULTS AND DISCUSSION 
3.1. Purification of S-ethylcysteinyl peptides 
Following incubation with ethanethiol in the 
presence of NaOH, the phosphorylated and 
dephosphorylated forms of the peptide 
SPQPSRRGSESSEE were rechromatographed on 
a Vydac Cl8 column (fig.1). The chemically 
modified phosphopeptide now eluted 11-13 min 
later at a 4% higher acetonitrile concentration (10 
vs 6%). The modified peptide was resolved into 
two major peaks, which after acid hydrolysis had 
identical amino acid compositions (table 1). Gas- 
phase sequencer and FABMS analysis revealed 
that both peaks had an identical sequence and the 
same molecular mass (not shown). Therefore, 
resolution of the modified peptide into two major 
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Fig.2. Amino acid analysis of the phosphopeptide 
SPQPSRRGS(P)ESSEE, after conversion to its 9 
ethylcysteine derivative. The peptide was hydrolysed for 
16 h at 110°C in 6 N HCl-2 mM phenol in the vapour 
phase in vacua. The hydrolysate was derivatised with 
phenylisothiocyanate as described in IS]. Ptc-amino 
acids were separated on a PICOTAG Crs column as 
described in the Waters Associates manual. 
components is not explained by deamidation of the 
glutamine residue, oxidation of S-ethylcysteine, or 
peptide bond cleavage. Amino acid analysis con- 
firmed that in both components, a single 
phosphoserine residue had been converted quan- 
titatively to S-ethylcysteine (table 1, fig.2). The 
phenylthiocarbamyl (Ptc) derivative of S- 
ethylcysteine was found to elute at 9.15 min be- 
tween Ptc-methionine (8.65 min) and Ptc-isoleu- 
tine (9.80 min) on the reverse-phase G18 column 
used for amino acid analysis (fig.2). These results 
demonstrate that the number of phosphoserine 
residues in a peptide can be quantified simply by 
chemical modification to S-ethylcysteine followed 
by amino acid analysis. Although the analysis il- 
lustrated in fig.2 was performed with 125 pmol 
peptide, as little as 10 pmol Ptc-S-ethylcysteine 
could be quantified by adjusting the sensitivity of 
the UV detector. 
Incubation of the dephosphopeptide with 
ethanethiol in NaOH did not significantly affect its 
elution from the Vydac column, although it now 
eluted as a doublet, as observed with the modified 
peptide (fig.1). Gas-phase sequencer and FABMS 
analyses (not shown) and amino acid analysis 
(table 1) showed that the doublet was not explained 
by partial deamidation, oxidation or peptide bond 
cleavage. The reason why incubation with 
ethanethiol in NaOH generates multiple forms of 
the peptide is unclear. One possibility is amino acid 
racemisation to generate isomeric species that are 
partially resolvable by reverse-phase liquid 
chromatography. 
Gas-phase sequencer analysis showed that S- 
ethylcysteine was the ninth residue in the modified 
peptide (not shown), the same site phosphorylated 
in the intact protein by cyclic AMP-dependent pro- 
tein kinase. Pth-S-ethylcysteine was eluted just 
before diphenylthiourea, as reported by Meyer et 
al. [3]. The other four serine residues were un- 
modified and therefore detected as Pth-serine and 
its dithiothreitol adduct. 
3.2. Purification of a diphosphopeptide from 
inhibitor-2 
It was of interest to apply the above procedure 
to a peptide containing more than one site of 
phosphorylation. Following digestion of inhibi- 
tor-2 with trypsin and chromatography of the 
digest on a Vydac column, FABMS revealed the 
presence of a diphosphorylated form of the pep- 
tide EQESSGEEDSDLSPEER, corresponding to 
residues 117-133 of the protein [8]. This peptide 
was eluted at 41 min, 4 min earlier than the 
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Fig.3. Separation of the diphosphopeptide 
EQES(P)S(P)GEEDSDLSPEER from contaminants, 
after conversion to its S-ethylcysteine derivative. 
Fractionation was carried out on a Vydac Crs column, 
as described in the legend to fig.1. 
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dephosphorylated derivative [6]. Since the 
diphosphopeptide was contaminated with other 
peptides, it was incubated with ethanethiol in 
NaOH and rechromatographed on the Vydac col- 
umn. As shown in fig.3 the peptide now eluted ap- 
prox. 25 min later at a 9% higher acetonitrile 
concentration (20 vs 11%). It was therefore com- 
pletely resolved from all contaminating peptides 
whose elution positions were unchanged. Amino 
acid analysis of the modified peptide established 
that two of the four serine residues had been con- 
verted to S-ethylcysteine (table 1). 
The presence of two S-ethylcysteine residues ex- 
plains the much later elution of the modified pep- 
tide from the Vydac column (fig.3). A monophos- 
phorylated form of EQESSGEEDSDLSPEER is 
also present in vivo, but at very low concentration 
[6]. The modified form of this peptide with one S- 
ethylcysteine residue is eluted from the column at 
15.5% acetonitrile between the unmodified form 
and the peptide with two S-ethylcysteine residues 
(not shown). This demonstrates the potential of 
the method for the separation of multiply 
phosphorylated peptides. 
The modified peptide containing two S- 
ethylcysteine residues was analysed on the gas- 
phase sequencer. S-Ethylcysteine was identified at 
residues 4 and 5, demonstrating that phospho- 
serine is present at these positions in vivo [6]. 
These sites are known to be phosphorylated in 
vitro by casein kinase II [9]. 
The procedures described in this paper provide a 
very sensitive method for identifying and purifying 
phosphoserine-containing peptides and do not re- 
quire the presence of a radioactive (32P) label. In 
conjunction with FABMS and the methodology 
described by Meyer et al. [3], they have recently 
been used to analyse the in vivo phosphorylation 
state of inhibitor-2 [6]. 
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